Gene and protein analysis reveals that p53 pathway is functionally inactivated in cytogenetically normal Acute Myeloid Leukemia and Acute Promyelocytic Leukemia

por Abramowitz, Julia, Neuman, Tzahi, Perlman, Riki, Ben-Yehuda, Dina
Publicado 2017

The oncogenic fusion protein CBFB-SMMHC downregulates CD48 to evade NK cell recognition

por Kahlon, Shira, Shreibman, Dorin, Unger, Tamar, Ben-Yehuda, Dina, Elias, Shlomo
Publicado 2018

tLivin Displays Flexibility by Promoting Alternative Cell Death Mechanisms

por Shiloach, Tamar, Berens, Christian, Danke, Christina, Waiskopf, Ortal, Perlman, Riki, Ben-Yehuda, Dina
Publicado 2014

From skepticism to openness: a qualitative narrative analysis of medical students’ attitudes following an integrative medicine course

por Ben-Arye, Eran, Finkelstein, Adi, Samuels, Noah, Ben-Yehuda, Dina, Schiff, Elad, Reis, Shmuel, Lesser, Lior, Bergel, Michael, Shaham, Dorith
Publicado 2022

From the "what" to the "how": Teaching integrative medicine-related skills to medical students during COVID-19

por Samuels, Noah, Shaham, Dorith, Schiff, Elad, Ben-Yehuda, Dina, Finkelstein, Adi, Lesser, Lior, Bergel, Michael, Reis, Shmuel, Ben-Arye, Eran
Publicado 2022

Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation

por Hodkinson, Brendan P., Schaffer, Michael, Brody, Joshua D., Jurczak, Wojciech, Carpio, Cecilia, Ben-Yehuda, Dina, Avivi, Irit, Forslund, Ann, Özcan, Muhit, Alvarez, John, Ceulemans, Rob, Fourneau, Nele, Younes, Anas, Balasubramanian, Sriram
Publicado 2020

COVID-19 Among Patients with Hematological Malignancies: Experience from a Tertiary Center Showing Lower Than Expected Mortality and Establishing the Safety of in-Hospital Patient...

por Aumann, Shlomzion, Tsubary, Uria, Israel, Sarah, Ben Yehuda, Dina, Lavie, David, Goldschmidt, Neta, Vainstein, Vladimir, Libster, Diana, Saban, Revital, Shaulov, Adir, Avni, Batia, Nachmias, Boaz, Grisariu, Sigal, Paltiel, Ora, Gatt, Moshe, Zimran, Eran
Publicado 2021

Ethnic variation in medical and lifestyle risk factors for B cell non-Hodgkin lymphoma: A case-control study among Israelis and Palestinians

por Kleinstern, Geffen, Abu Seir, Rania, Perlman, Riki, Khatib, Areej, Abdeen, Ziad, Elyan, Husein, Nirel, Ronit, Amir, Gail, Ramlawi, Asad, Sabatin, Fouad, Boffetta, Paolo, Dann, Eldad J., Kedmi, Meirav, Ellis, Martin, Nagler, Arnon, Ben Yehuda, Dina, Paltiel, Ora
Publicado 2017

Genetic Variation in DNA Repair Pathways and Risk of Non-Hodgkin's Lymphoma

por Rendleman, Justin, Antipin, Yevgeniy, Reva, Boris, Adaniel, Christina, Przybylo, Jennifer A., Dutra-Clarke, Ana, Hansen, Nichole, Heguy, Adriana, Huberman, Kety, Borsu, Laetitia, Paltiel, Ora, Ben-Yehuda, Dina, Brown, Jennifer R., Freedman, Arnold S., Sander, Chris, Zelenetz, Andrew, Klein, Robert J., Shao, Yongzhao, Lacher, Mortimer, Vijai, Joseph, Offit, Kenneth, Kirchhoff, Tomas
Publicado 2014

A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previous...

por Trnĕný, Marek, Verhoef, Gregor, Dyer, Martin JS, Ben Yehuda, Dina, Patti, Caterina, Canales, Miguel, Lopez, Andrés, Awan, Farrukh T, Montgomery, Paul G, Janikova, Andrea, Barbui, Anna M, Sulek, Kazimierz, Terol, Maria J, Radford, John, Guidetti, Anna, Di Nicola, Massimo, Siraudin, Laure, Hatteville, Laurence, Schwab, Sandrine, Oprea, Corina, Gianni, Alessandro M
Publicado 2018

Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs

por Montefusco, Vittorio, Gay, Francesca, Spada, Stefano, De Paoli, Lorenzo, Di Raimondo, Francesco, Ribolla, Rossella, Musolino, Caterina, Patriarca, Francesca, Musto, Pellegrino, Galieni, Piero, Ballanti, Stelvio, Nozzoli, Chiara, Cascavilla, Nicola, Ben-Yehuda, Dina, Nagler, Arnon, Hajek, Roman, Offidani, Massimo, Liberati, Anna Marina, Sonneveld, Pieter, Cavo, Michele, Corradini, Paolo, Boccadoro, Mario
Publicado 2020

Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial

por Dimopoulos, Meletios A., Oriol, Albert, Nahi, Hareth, San-Miguel, Jesus, Bahlis, Nizar J., Usmani, Saad Z., Rabin, Neil, Orlowski, Robert Z., Suzuki, Kenshi, Plesner, Torben, Yoon, Sung-Soo, Ben Yehuda, Dina, Richardson, Paul G., Goldschmidt, Hartmut, Reece, Donna, Ahmadi, Tahamtan, Qin, Xiang, Garvin Mayo, Wendy, Gai, Xue, Carey, Jodi, Carson, Robin, Moreau, Philippe
Publicado 2023

Susceptibility Loci Associated with Specific and Shared Subtypes of Lymphoid Malignancies

por Vijai, Joseph, Kirchhoff, Tomas, Schrader, Kasmintan A., Brown, Jennifer, Dutra-Clarke, Ana Virginia, Manschreck, Christopher, Hansen, Nichole, Rau-Murthy, Rohini, Sarrel, Kara, Przybylo, Jennifer, Shah, Sohela, Cheguri, Srujana, Stadler, Zsofia, Zhang, Liying, Paltiel, Ora, Ben-Yehuda, Dina, Viale, Agnes, Portlock, Carol, Straus, David, Lipkin, Steven M., Lacher, Mortimer, Robson, Mark, Klein, Robert J., Zelenetz, Andrew, Offit, Kenneth
Publicado 2013

Randomized, placebo‐controlled, phase 3 study of perifosine combined with bortezomib and dexamethasone in patients with relapsed, refractory multiple myeloma previously treated wit...

por Richardson, Paul G., Nagler, Arnon, Ben‐Yehuda, Dina, Badros, Ashraf, Hari, Parameswaran N., Hajek, Roman, Spicka, Ivan, Kaya, Hakan, LeBlanc, Richard, Yoon, Sung‐Soo, Kim, Kihyun, Martinez‐Lopez, Joaquin, Mittelman, Moshe, Shpilberg, Ofer, Blake, Paul, Hideshima, Teru, Colson, Kathleen, Laubach, Jacob P., Ghobrial, Irene M., Leiba, Merav, Gatt, Moshe E., Sportelli, Peter, Chen, Michael, Anderson, Kenneth C.
Publicado 2020